SEARCH
FDA Announces Recall of Blood Pressure Medications Over High Levels of Possible Carcinogenic—Here's What to Do
Health Magazine
2021-10-21
Views
726
Description
Share / Embed
Download This Video
Report
The voluntary recall by Lupin Pharmaceuticals involves Irbesartan tablets as well as its Irbesartan and Hydrochlorothiazide tablets.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x850gfp" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:37
J&J Issues Recall of 5 Sunscreens After Testing Detects Low Levels of Carcinogen
00:43
Diabetes Drug Metformin Recalled Over Presence of NDMA, a Possible Carcinogen—Here's What to Know
01:00
Donald Trump's COVID-19 Treatment Plan: What to Know About The President's Medications
00:55
7 Medications That May Make You Extra Sensitive to Sun and Heat
01:08
I Tried 19 Medications and 5 Years of Therapy for My Suicidal Thoughts Until I Found Somet
00:42
FDA Approves Apretude, the First Injectable PrEP Medication—Here's Why That's a Big Deal
00:53
7 Medications That May Make You Extra Sensitive to Sun and Heat
00:36
7 Types of Vitafusion Gummy Vitamins Are Being Recalled, According to the FDA—Here's What
00:56
More Than 500,000 At-Home COVID Tests Recalled, FDA Warns of Bacteria Risk
00:52
An Anti-Anxiety Medication Was Just Recalled Due to a 'Risk of Infection'—Here's What to Know
00:46
Blood Pressure Increased 'Significantly' in Adults During COVID—Here's What Researchers Think Led to the Rise
01:01
What Causes High Blood Pressure? How To Minimize Your Risk